SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-012296
Filing Date
2020-05-14
Accepted
2020-05-14 16:32:27
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_biomxinc.htm 10-Q 327988
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CHARDAN HEALTHCARE A f10q0320ex3-1_biomxinc.htm EX-3.1 23691
3 CERTIFICATION f10q0320ex31-1_biomxinc.htm EX-31.1 11467
4 CERTIFICATION f10q0320ex31-2_biomxinc.htm EX-31.2 11503
5 CERTIFICATION f10q0320ex32_biomxinc.htm EX-32 5395
  Complete submission text file 0001213900-20-012296.txt   2302080

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE phge-20200331.xml EX-101.INS 312893
7 XBRL SCHEMA FILE phge-20200331.xsd EX-101.SCH 36368
8 XBRL CALCULATION FILE phge-20200331_cal.xml EX-101.CAL 33102
9 XBRL DEFINITION FILE phge-20200331_def.xml EX-101.DEF 102414
10 XBRL LABEL FILE phge-20200331_lab.xml EX-101.LAB 233939
11 XBRL PRESENTATION FILE phge-20200331_pre.xml EX-101.PRE 185337
Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 20878326
SIC: 2836 Biological Products, (No Diagnostic Substances)